Items where authors include "Flechtner, H-H"

Article

Musoro, JZ, Coens, C, Sprangers, MAG et al. (18 more authors) (2023) Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types. European Journal of Cancer, 188. pp. 171-182. ISSN 0959-8049

Koller, M, Musoro, JZ, Tomaszewski, K et al. (8 more authors) (2022) Corrigendum to “Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma – Interpretation guidance derived from two randomized EORTC trials” [Lung Cancer 167C (2022) 65–72]. Lung Cancer, 171. p. 126. ISSN 0169-5002

Koller, M, Musoro, JZ, Tomaszewski, K et al. (8 more authors) (2022) Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma – Interpretation guidance derived from two randomized EORTC trials. Lung Cancer. ISSN 0169-5002

Gamper, EM, Musoro, JZ, Coens, C et al. (9 more authors) (2021) Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials. BMC cancer, 21 (1). 1083. ISSN 1471-2407

Dirven, L, Musoro, JZ, Coens, C et al. (13 more authors) (2021) Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients. Neuro-Oncology, 23 (8). pp. 1327-1336. ISSN 1522-8517

Musoro, JZ, Coens, C, Greimel, E et al. (10 more authors) (2020) Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer. Gynecologic Oncology, 159 (2). pp. 515-521. ISSN 0090-8258

Coens, C, Pe, M, Dueck, AC et al. (32 more authors) (2020) International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium. The Lancet Oncology, 21 (2). e83-e96. ISSN 1470-2045

Bottomley, A, Pe, M, Sloan, J et al. (38 more authors) (2018) Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials. Clinical Trials, 15 (6). pp. 624-630. ISSN 1740-7745

Musoro, JZ, Bottomley, A, Coens, C et al. (8 more authors) (2018) Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma. European Journal of Cancer, 104. pp. 169-181. ISSN 0959-8049

Pe, M, Dorme, L, Coens, C et al. (29 more authors) (2018) Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review. The Lancet Oncology, 19 (9). E459-E469. ISSN 1470-2045

Musoro, ZJ, Hamel, J-F, Ediebah, DE et al. (10 more authors) (2018) Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol. BMJ Open, 8 (1). e019117.

Bottomley, A, Pe, M, Sloan, J et al. (36 more authors) (2016) Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards. Lancet Oncology, 17 (11). e510-e514. ISSN 1470-2045